7.2 Postmortem Redistribution (PMR), Vd & Toxicological Pharmacokinetics

Biophysical Pathophysiology of Postmortem Redistribution (PMR)

Following somatic cardiac arrest, cellular respiration and adenosine triphosphate (ATP) production instantly terminate. Within minutes, the loss of active, energy-dependent transmembrane transport systems disrupts cellular ionic equilibrium, allowing intracellular calcium, sodium, and water influx. Intracellular lysosomes swell, destabilize, and rupture, releasing potent acid hydrolases, proteases, and lipases that initiate progressive autolysis. Concurrently, vascular endothelial barriers disintegrate, and cellular tight junctions break down, transforming the body into a static biophysical system governed entirely by thermodynamic entropy and passive molecular diffusion.

Postmortem Redistribution (PMR) refers to the passive, time-dependent movement of drugs down steep concentration gradients from solid tissue reservoirs—specifically organ systems that sequester high drug masses during life (such as the lungs, liver, myocardium, and gastrointestinal mucosa)—into adjacent quiescent vascular spaces. Consequently, drug concentrations measured in blood samples harvested postmortem often do not reflect the pharmacologically active circulating concentration present at the moment of death.

+------------------------------------------------------------------------------------------------+
|                      ANATOMICAL VECTORS OF POSTMORTEM REDISTRIBUTION                           |
+------------------------------------------------------------------------------------------------+
  HIGH-CONCENTRATION TISSUE RESERVOIR            RECIPIENT VASCULAR COMPARTMENT
  
  [ Pulmonary Parenchyma (Lungs) ]   -------->   [ Pulmonary Veins & Left Atrium / Ventricle ]
  
  [ Myocardium (Heart Muscle) ]       -------->   [ Cardiac Chambers (Right & Left Ventricles) ]
  
  [ Hepatic Parenchyma (Liver) ]      -------->   [ Inferior Vena Cava & Hepatic Veins ]
  
  [ Gastric Mucosa / Residual Bolus ] -------->   [ Left Liver Lobe, Portal Vein & Pericardium ]
  
  [ Mesenteric Adipose ]              -------->   [ Pelvic & Abdominal Venous System ]

Cellular Mechanisms: Lysosomal Ion Trapping and Transcellular Transudation

The cellular storage of basic drugs is governed by lysosomal ion trapping. In living cells, the acidic lumen of intracellular lysosomes (pH ≈ 4.5 - 5.0) creates a steep pH gradient relative to the neutral cytosol (pH ≈ 7.2). Basic drugs (pKa > 7.4 - 9.5) readily diffuse across the lipophilic lysosomal membrane in their uncharged, unionized state. Once inside the acidic lysosomal compartment, the molecules become protonated (ionized). In their charged form, they are membrane-impermeant and become trapped at concentrations up to 1,000-fold higher than in surrounding cytoplasm. Upon somatic death and cellular autolysis, the lysosomal membranes hydrolyze, dumping massive stores of concentrated basic drugs into the cytosol, from which they passively transudate through ruptured endothelial walls into neighboring blood vessels.

---

Pharmacokinetic Determinants: Volume of Distribution (Vd), Lipophilicity, and pKa

Not all pharmacological agents undergo postmortem redistribution. Susceptibility to PMR is dictated by three intrinsic physicochemical and pharmacokinetic properties:

1. Apparent Volume of Distribution (Vd): The theoretical volume of fluid into which the total amount of drug in the body would have to be uniformly distributed to yield the measured plasma concentration:

   Vd = (Total Amount of Drug in Body) / (Plasma Drug Concentration)

   • Low Vd (< 1.0 L/kg): The drug is hydrophilic, polar, or highly bound to circulating plasma albumin. It remains overwhelmingly confined to the circulating vascular compartment and extracellular water. Such agents demonstrate minimal to zero PMR. Examples include ethanol (Vd ≈ 0.6 L/kg), salicylic acid (Vd ≈ 0.15 L/kg), phenytoin (Vd ≈ 0.6 L/kg), warfarin (Vd ≈ 0.15 L/kg), and lithium (Vd ≈ 0.7 L/kg).
   • High Vd (> 3.0 - 4.0 L/kg): The drug is lipophilic, poorly water-soluble, and concentrates heavily in extravascular tissue depots (adipose, lungs, brain, liver). When Vd exceeds total physiological body water (approximately 0.6 L/kg in adult humans), tissue concentrations vastly eclipse circulating blood concentrations. Such agents demonstrate profound PMR. Examples include tricyclic antidepressants (amitriptyline Vd ≈ 15 - 20 L/kg), digoxin (Vd ≈ 6 - 8 L/kg), fentanyl (Vd ≈ 4 - 6 L/kg), methamphetamine (Vd ≈ 3 - 5 L/kg), diphenhydramine (Vd ≈ 4 - 6 L/kg), and chlorpromazine (Vd ≈ 20 L/kg).

2. Acid-Base Chemistry (pKa): Basic amines (pKa > 7.4) undergo extensive cellular uptake and lysosomal trapping. Conversely, acidic drugs (pKa < 5.0) remain largely ionized at physiological pH and bound to circulating albumin, resisting cellular sequestration and redistribution.

3. Lipophilicity (Octanol-Water Partition Coefficient, log P): Compounds with high log P rapidly penetrate cellular lipid bilayers and concentrate in fatty organs, providing large reservoirs available for postmortem desorption.

---

The Central-to-Peripheral (C/P) Ratio: Diagnostic Interpretation

To evaluate the magnitude of redistribution for a given compound in casework, forensic toxicologists calculate the Central-to-Peripheral (C/P) Ratio:

C/P Ratio = (Drug Concentration in Central Cardiac Blood) / (Drug Concentration in Peripheral Femoral Blood)

Clinical and Investigative Rules for C/P Interpretation:

• C/P ≈ 1.0 (0.8 - 1.2): Denotes absence of significant redistribution. Blood concentrations drawn from cardiac chambers or peripheral vessels are virtually interchangeable (e.g., ethanol, carboxyhemoglobin, paracetamol/acetaminophen).
• C/P Between 1.5 and 2.5: Denotes moderate redistribution. Cardiac blood concentrations are mildly to moderately inflated. Peripheral femoral blood must be utilized for quantitative interpretation, but cardiac blood provides a reasonable backup if properly documented.
• C/P > 3.0 (and up to 10+): Denotes severe, volatile redistribution. Cardiac blood concentrations are dramatically inflated due to passive diffusion from adjacent myocardial or pulmonary parenchymal depots.

The Deadly Forensic Trap: Consider a decedent whose cardiac blood amitriptyline concentration is measured at 3.2 mg/L (a level widely recognized in clinical literature as fatal), but whose clamped femoral blood concentration is only 0.4 mg/L (a therapeutic or sub-lethal concentration). If the investigator or prosector collected only cardiac blood—or if the toxicologist analyzed cardiac blood without knowing its anatomical origin—the death would be erroneously certified as a fatal suicidal tricyclic antidepressant overdose! When the true femoral concentration is recognized, the C/P ratio of 8.0 exposes the cardiac level as a postmortem artifact, forcing the investigator to seek the real cause of death (such as subtle asphyxia or natural arrhythmia).

+------------------------------------------------------------------------------------------------+
|                       WORKED FORENSIC CALCULATION: AMITRIPTYLINE                               |
+------------------------------------------------------------------------------------------------+
  Decedent: 70 kg Adult Male found deceased in bed. History of Depression.
  
  Toxicology Results:
    - Cardiac Blood Amitriptyline: 2.80 mg/L
    - Femoral Blood Amitriptyline: 0.35 mg/L
    - Vitreous Humor Amitriptyline: 0.05 mg/L
  
  Step 1: Calculate C/P Ratio:
          C/P = (2.80 mg/L) / (0.35 mg/L) = 8.0
  
  Step 2: Evaluate Pharmacokinetics:
          Amitriptyline Vd = 16 L/kg; pKa = 9.4 (Highly lipophilic basic amine).
          Therapeutic Range: 0.10 - 0.25 mg/L
          Toxic Range: 0.50 - 1.00 mg/L
          Lethal Threshold: > 1.50 - 2.00 mg/L
  
  Step 3: Medicolegal Conclusion:
          The cardiac concentration (2.80 mg/L) falsely suggests massive lethal overdose.
          However, the peripheral femoral concentration (0.35 mg/L) reflects mild therapeutic
          elevation (non-lethal). The C/P ratio of 8.0 is a textbook demonstration of PMR
          from massive myocardial and pulmonary drug stores into the cardiac lumen.
          Amitriptyline toxicity is ruled OUT as the primary immediate cause of death.

---

Postmortem Microbial Ethanol Synthesis vs. Antemortem Ingestion

Ethanol is the single most common toxicological agent detected in medicolegal casework. However, identifying ethanol in a postmortem blood sample does not automatically prove that the decedent consumed alcoholic beverages prior to death. In decomposing, traumatized, or thermally injured bodies, postmortem microbial fermentation can synthesize substantial quantities of endogenous ethanol de novo.

The Fermentation Cascade

Normal enteric bacteria (Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis) and ubiquitous fungal yeasts (Candida albicans, Saccharomyces cerevisiae) proliferate rapidly following somatic death. As intestinal mucosal integrity fails, these microorganisms translocate through the mesenteric vasculature and portal system into the general circulation. Utilizing endogenous, unabsorbed carbohydrates (glucose, glycogen), lactate, and amino acids as metabolic substrates, these microbes produce ethanol via the anaerobic pyruvate decarboxylase and alcohol dehydrogenase pathways:

Glucose → 2 Pyruvate → 2 Acetaldehyde → 2 Ethanol + 2 CO2

Under favorable ambient temperatures (> 25°C / 77°F), putrefactive microbial synthesis can produce blood ethanol concentrations exceeding 0.08 - 0.15 g/dL (and occasionally up to 0.20 g/dL) within 48 to 72 hours in a completely sober decedent.

Diagnostic Triangulation Protocol to Verify True Antemortem Ingestion

To definitively distinguish true antemortem alcohol intake from putrefactive microbial synthesis, the forensic investigator must execute a multi-matrix analytical strategy:

1. Vitreous Humor Ethanol Comparison: The vitreous chamber is an avascular, sterile compartment containing minimal glucose (typically < 100 mg/dL in non-diabetics) and no resident microflora. Microbes cannot penetrate the intact eyeball during early-to-moderate decomposition. Because ethanol is completely water-soluble, it distributes across total body water. The water content of whole blood is approximately 80%, whereas vitreous humor is approximately 98% to 99% water. In the fully absorbed, post-absorptive equilibrium state, the Vitreous-to-Blood Ethanol Ratio (V/B) is approximately 1.15 - 1.25.
   • Antemortem Ingestion: Blood ethanol = 0.12 g/dL; Vitreous ethanol = 0.14 g/dL. Vitreous ethanol correlates with blood ethanol based on water content. True antemortem intake is confirmed.
   • Microbial Synthesis: Blood ethanol = 0.10 g/dL; Vitreous ethanol = 0.00 g/dL. Zero alcohol in the protected vitreous chamber proves that the blood alcohol arose entirely from postmortem microbial fermentation.
2. Urine Ethanol Comparison: Urine water content is approximately 99%. In the post-absorptive phase, the Urine-to-Blood Ratio (U/B) typically averages 1.25 - 1.35. Finding high blood alcohol with zero urine alcohol in a full bladder strongly indicates postmortem fermentation (or rapid death occurring in the ultra-early absorption phase, < 15 minutes post-ingestion).
3. Volatile Congener Profiling (n-Propanol Analysis): Microbial fermentation produces a characteristic fingerprint of higher aliphatic alcohols and metabolic byproducts, specifically n-propanol, isopropanol, isobutanol, and acetaldehyde. Beverage alcohol fermentations utilized for human consumption contain virtually zero n-propanol. The detection of n-propanol alongside ethanol via headspace gas chromatography with flame ionization detection (GC-FID) serves as an objective chemical biomarker of active microbial putrefaction.
4. Non-Oxidative Minor Ethanol Metabolites: Ethyl Glucuronide (EtG) and Ethyl Sulfate (EtS):
   • EtG and EtS are polar, non-oxidative direct metabolites of ethanol formed in trace quantities (accounting for < 0.1% of ethanol clearance). They are synthesized exclusively by human hepatic enzymes—specifically, UDP-glucuronosyltransferases (UGT) conjugate ethanol with glucuronic acid to form EtG, while sulfotransferases (SULT) conjugate ethanol with inorganic sulfate to form EtS.
   • Putrefactive bacteria and yeasts possess neither UGT nor human sulfotransferase pathways; microorganisms cannot synthesize EtG or EtS. Finding EtG and EtS in postmortem blood, urine, or tissue conclusively proves that human in vivo metabolism occurred prior to death, definitively verifying antemortem ethanol exposure even in moderately decomposing remains.